Search research articles
Contact Us
Filters
Showing results (11-20 of 191) with videos related to
Page
of 20
Sort By:
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
November 2, 2010
Mycobacterium avium paratuberculosis and the etiology of Crohn's disease: a review of the controversy from the clinician's perspective
Greg Rosenfeld, Brian Bressler
Digestive Diseases and Sciences
|
October 29, 2013
Effective tuberculosis and hepatitis screening prior to anti-TNF-α therapy: are we there yet?
Neal Shahidi, Brian Bressler
Drugs
|
November 20, 2008
Mild to moderate Crohn's disease: an evidence-based treatment algorithm
Karen Wong, Brian Bressler
Alimentary Pharmacology & Therapeutics
|
October 19, 2019
Editorial: aminosalicylates and nephrotoxicity-an issue put to rest
Shankar Menon, Brian Bressler
The American Journal of Gastroenterology
|
September 7, 2012
The truth about cigarette smoking and the risk of inflammatory bowel disease
Greg Rosenfeld, Brian Bressler
Immunotherapy
|
October 24, 2014
Vedolizumab for ulcerative colitis and Crohn's disease: results and implications of GEMINI studies
Mindy Cw Lam, Brian Bressler
Expert Review of Gastroenterology & Hepatology
|
December 17, 2008
Natalizumab: pharmacology, clinical efficacy and safety in the treatment of patients with Crohn's disease
Hin Hin Ko, Brian Bressler
Gastroenterology
|
March 1, 2014
Beware of the swinging pendulum: anti-tumor necrosis factor monotherapy vs combination therapy for inflammatory bowel disease
Brian Bressler, Corey A Siegel
Gastroenterology
|
June 26, 2012
A tale of two cohorts: are we overestimating the risk of colorectal cancer in inflammatory bowel disease?
Geoffrey C Nguyen, Brian Bressler
Digestive Diseases and Sciences
|
May 17, 2019
Acute Severe Ulcerative Colitis: The Oxford Criteria No Longer Predict In-Hospital Colectomy Rates
Alice C Moore, Brian Bressler
Page
of 20
Search research articles
Search
Showing results (11-20 of 191) with videos related to
Sort By:
Page
of 20
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
November 2, 2010
Mycobacterium avium paratuberculosis and the etiology of Crohn's disease: a review of the controversy from the clinician's perspective
Greg Rosenfeld, Brian Bressler
Digestive Diseases and Sciences
|
October 29, 2013
Effective tuberculosis and hepatitis screening prior to anti-TNF-α therapy: are we there yet?
Neal Shahidi, Brian Bressler
Drugs
|
November 20, 2008
Mild to moderate Crohn's disease: an evidence-based treatment algorithm
Karen Wong, Brian Bressler
Alimentary Pharmacology & Therapeutics
|
October 19, 2019
Editorial: aminosalicylates and nephrotoxicity-an issue put to rest
Shankar Menon, Brian Bressler
The American Journal of Gastroenterology
|
September 7, 2012
The truth about cigarette smoking and the risk of inflammatory bowel disease
Greg Rosenfeld, Brian Bressler
Immunotherapy
|
October 24, 2014
Vedolizumab for ulcerative colitis and Crohn's disease: results and implications of GEMINI studies
Mindy Cw Lam, Brian Bressler
Expert Review of Gastroenterology & Hepatology
|
December 17, 2008
Natalizumab: pharmacology, clinical efficacy and safety in the treatment of patients with Crohn's disease
Hin Hin Ko, Brian Bressler
Gastroenterology
|
March 1, 2014
Beware of the swinging pendulum: anti-tumor necrosis factor monotherapy vs combination therapy for inflammatory bowel disease
Brian Bressler, Corey A Siegel
Gastroenterology
|
June 26, 2012
A tale of two cohorts: are we overestimating the risk of colorectal cancer in inflammatory bowel disease?
Geoffrey C Nguyen, Brian Bressler
Digestive Diseases and Sciences
|
May 17, 2019
Acute Severe Ulcerative Colitis: The Oxford Criteria No Longer Predict In-Hospital Colectomy Rates
Alice C Moore, Brian Bressler
Page
of 20